Study Reveals Improved Screening Protocol for Detecting Stage 1 Pancreatic Cancer

A new study found stage 1 pancreatic cancer is more likely to be identified with the tumor marker CA 19-9 and targeted endoscopic ultrasound than with standard means of detection, according to a news release the American Society for Gastrointestinal Endoscopy.

 

The study, appearing in the society's journal, GIE: Gastrointestinal Endoscopy, found that a patient detected with the new screening protocol was alive without evidence of recurrence three years after surgical resection.

 

The study said costs of the new screening protocol were acceptable: $8,431 to detect pancreatic neoplasia and $41,133 to detect pancreatic cancer.

 

Read the American Society for Gastrointestinal Endoscopy release on pancreatic cancer detection (pdf).


Related Articles on Pancreatic Cancer:

Expert Cautions Findings on Pancreatic Cancer Screening

New Research Supports Previous Studies Aspirin Reduces Risk of CRC

Study: Endoscopic Ultrasound Associated With Improved Pancreatic Cancer Outcomes

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast